{
    "title": "Biopharma firm Acelyrin valued at $2.1 billion in strong market debut",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12051729/Biopharma-firm-Acelyrin-valued-2-1-billion-strong-market-debut.html",
    "date": "2023-05-05",
    "keywords": [
        "inc",
        "offering",
        "acelyrin",
        "company",
        "ipo",
        "johnson",
        "nasdaq",
        "debut",
        "friday",
        "biopharma",
        "market",
        "capitalization",
        "los",
        "spate",
        "recovery",
        "amp",
        "consumer",
        "health",
        "business",
        "kenvue",
        "ground",
        "halt",
        "year",
        "investor",
        "appetite",
        "interestrate",
        "volatility",
        "cowen",
        "piper",
        "sandler",
        "bookrunning",
        "reporting",
        "jaiveer",
        "singh",
        "shekhawat",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}